Adjuvant radiotherapy shows benefit in selected stage I uterine sarcoma: A risk scoring system based on a population analysis

BACKGROUND: The potential therapeutic benefit of adjuvant radiotherapy for patients with stage I uterine sarcoma has not been clear. In this study, we aimed to develop a risk scoring model to select the subgroup of patients with stage I uterine sarcoma who might benefit from adjuvant radiotherapy. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yun‐xia, Lin, Yan‐zong, Li, Yi‐min, Chu, Ke‐xin, Zhou, Yu‐fei, Lin, Li‐mei, Zhou, Rui, Zhang, Zong‐kai, Lin, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302311/
https://www.ncbi.nlm.nih.gov/pubmed/35277934
http://dx.doi.org/10.1002/cam4.4643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302311/
https://www.ncbi.nlm.nih.gov/pubmed/35277934
http://dx.doi.org/10.1002/cam4.4643

Ejemplares similares